Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
7.46
-0.17 (-2.23%)
Dec 3, 2024, 12:38 PM EST - Market open

Company Description

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States.

The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures.

It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products.

The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022.

Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Lifecore Biomedical, Inc.
Lifecore Biomedical logo
Country United States
Founded 1986
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 524
CEO Paul Josephs

Contact Details

Address:
3515 Lyman Boulevard
Chaska, Minnesota 55318
United States
Phone (952) 368-4300
Website lifecore.com

Stock Details

Ticker Symbol LFCR
Exchange NASDAQ
Fiscal Year June - May
Reporting Currency USD
CIK Code 0001005286
ISIN Number US5147661046
Employer ID 94-3025618
SIC Code 2834

Key Executives

Name Position
Paul Josephs President, Chief Executive Officer and Director
James G. Hall Advisor
Ryan D. Lake CPA Chief Financial Officer and Secretary
Aaron Perlitsh Director of Internal Audit and Chief Compliance Officer
Darren M. Hieber Senior Vice President of Corporate Development and Partnerships
Brikkelle Thompson Senior Vice President of Human Resources
Jackie Q. Klecker Executive Vice President, Quality and Development Services and GM
Matt Augustson Senior Vice President of Information Technology
Dr. Albert D. Bolles Ph.D. President of Curation Foods, Inc.
Parker K. Javid Vice President

Latest SEC Filings

Date Type Title
Nov 26, 2024 8-K Current Report
Nov 21, 2024 8-K Current Report
Nov 20, 2024 144 Filing
Nov 12, 2024 144 Filing
Nov 8, 2024 8-K Current Report
Oct 31, 2024 144 Filing
Oct 23, 2024 424B3 Prospectus
Oct 22, 2024 EFFECT Notice of Effectiveness
Oct 18, 2024 UPLOAD Filing
Oct 15, 2024 EFFECT Notice of Effectiveness